Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 99.76%
August 31, 2026 99.76%
July 31, 2026 99.76%
June 30, 2026 99.76%
May 31, 2026 99.76%
April 30, 2026 99.76%
March 31, 2026 99.76%
February 28, 2026 99.76%
January 31, 2026 99.76%
December 31, 2025 99.76%
November 30, 2025 99.76%
October 31, 2025 99.76%
September 30, 2025 99.76%
August 31, 2025 99.76%
July 31, 2025 99.76%
June 30, 2025 99.76%
May 31, 2025 99.76%
April 30, 2025 99.76%
March 31, 2025 99.76%
February 28, 2025 99.76%
January 31, 2025 99.76%
December 31, 2024 99.76%
November 30, 2024 99.76%
October 31, 2024 99.76%
September 30, 2024 99.76%
Date Value
August 31, 2024 99.76%
July 31, 2024 99.76%
June 30, 2024 99.76%
May 31, 2024 99.76%
April 30, 2024 99.76%
March 31, 2024 99.76%
February 29, 2024 99.76%
January 31, 2024 99.76%
December 31, 2023 99.76%
November 30, 2023 99.76%
October 31, 2023 99.76%
September 30, 2023 99.76%
August 31, 2023 99.76%
July 31, 2023 99.76%
June 30, 2023 99.74%
May 31, 2023 99.74%
April 30, 2023 99.53%
March 31, 2023 99.44%
February 28, 2023 99.44%
January 31, 2023 99.44%
December 31, 2022 99.19%
November 30, 2022 99.17%
October 31, 2022 99.17%
September 30, 2022 99.17%
August 31, 2022 98.91%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Quest Diagnostics, Inc. 28.60%
Labcorp Holdings, Inc. 34.60%
OPKO Health, Inc. 85.55%
Psychemedics Corp. 87.72%
NeoGenomics, Inc. 91.92%